Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Sell
2,773
-367
-12% -$126K 0.07% 194
2026
Q1
$1.1M Sell
3,140
-1,753
-36% -$625K 0.08% 172
2025
Q4
$1.6M Sell
4,893
-347
-7% -$110K 0.13% 110
2025
Q3
$1.48M Sell
5,240
-100
-2% -$29K 0.13% 102
2025
Q2
$1.49M Buy
5,340
+322
+6% +$91.2K 0.15% 99
2025
Q1
$1.56M Buy
5,018
+1,021
+26% +$301K 0.18% 79
2024
Q4
$1.04M Buy
3,997
+1,031
+35% +$306K 0.12% 115
2024
Q3
$956K Buy
2,966
+234
+9% +$76.5K 0.1% 157
2024
Q2
$853K Sell
2,732
-350
-11% -$103K 0.09% 176
2024
Q1
$876K Buy
3,082
+1,068
+53% +$313K 0.1% 180
2023
Q4
$580K Buy
2,014
+780
+63% +$213K 0.08% 199
2023
Q3
$332K Buy
1,234
+193
+19% +$48.2K 0.05% 222
2023
Q2
$231K Buy
+1,041
New +$242K 0.04% 270
2020
Q4
Sell
-1,238
Closed -$315K 140
2020
Q3
$315K Sell
1,238
-939
-43% -$233K 0.13% 79
2020
Q2
$513K Buy
+2,177
New +$497K 0.31% 65

Other funds holding AMGN

Advisor OS's AMGN Position: Q2 2026 in Review

Advisor OS reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $126K and leaving 2,773 shares worth $1M. The position accounts for 0.07% of the portfolio, ranked #194.

Advisor OS first reported a position in AMGN in Q2 2020 and has held it in 15 quarters since. The position peaked at $1.6M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Advisor OS held 2,773 shares of Amgen worth $1M as of Q2 2026.
  • Advisor OS sold 367 Amgen shares in Q2 2026, an estimated $126K.
  • Amgen made up 0.07% of Advisor OS's portfolio in Q2 2026, its #194 holding.
  • Advisor OS first reported a position in Amgen in Q2 2020 and has held it in 15 quarters since.
  • Advisor OS's Amgen position peaked at $1.6M in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advisor OS's 13F filing for Q2 2026, filed 5 Aug 2026.